Background Image
Table of Contents Table of Contents
Previous Page  118 / 302 Next Page
Information
Show Menu
Previous Page 118 / 302 Next Page
Page Background

Sample Preparation

Wastewater samples were filtered using 1.2 µm pore-size

fiber glass filters and then 0.45 µm pore-size mixed cellu-

lose membranes. 50 mM of formic acid and 1 mL of a

5% Na

2

EDTA (w/v) solution were added to 250 mL of

wastewater and the pH adjusted to 3 with NaOH 1.0 M.

Pyrimethamine was used as a surrogate standard and

spiked at a concentration of 500 ng L

-1

.

Analytes were pre-concentrated and extracted using a

200 mg reversed phase polymeric SPE cartridge on top of

a 200 mg mixed mode polymeric SPE cartridge. Retained

analytes were eluted from the cartridges using 2

×

2.5 mL

ACN: MeOH 1:1 (reversed phase) and 2

×

2.5 mL 5%

NH

3

in ACN: MeOH 1:1 (mixed mode). The eluates were

recovered from both cartridges and were collected on the

same conical-bottom centrifuge tube and then evaporated

to dryness with N

2

(g)

. Extracted analytes were reconsti-

tuted to 250 µL with 0.1% formic acid in 90% H

2

O/5%

MeOH/5% ACN solution containing the internal stan-

dards (diaveridine, lomefloxacin and josamycin).

LC-MS/MS Conditions

HPLC separation was done with a Thermo Scientific

Surveyor HPLC system. Detection and quantification of

the analytes was performed with a Thermo Scientific TSQ

Quantum Ultra using the single reaction monitoring mode

(SRM) (Table 1). Two specific single reaction monitoring

(SRM) transitions were used for each compound as well

as their peak area ratios to reliably confirm the presence

of the targeted anti-infectives. This reduced the possibility

of false positives given that some interfering matrix com-

ponents areco-extracted with the analytes and could have

the same SRM transition.

[8]

Results and Discussion

MS/MS in the SRM mode proved to be highly selective.

Instrument response was linear (

r

2

0.99) in the dynamic

range (25–1000 ng L

-1

) in spite of the presence of high

concentrations of organic as well as inorganic interfer-

ences in the matrix. Limits of detection ranged from

Table 1: Instrument Parameters

HPLC

MS

Column

Thermo Scientific BetaBasic

C18

(50

×

2.1 mm, 3 µm)

Ionization mode

ESI+

Column temperature

30°C

Spray voltage

3500 V

Mobile phase A

0.1 % formic acid/H

2

O

Ion transfer capillary temperature

350 ºC

Mobile phase B

0.1% formic acid

/MeOH:ACN

1:1

Sheath gas pressure

21 mTorr

Injection volume

20 µL

Auxiliary gas pressure

4 mTorr

Flow rate

200 µLmin

-1

Collision gas pressure

1.5 mTorr

Gradient

t=0 min, A=90%, B=10%

Source CID

–12 V

t=2 min, A=80%, B=20%

t=15 min, A=75%, B=25%

t=17 min, A=50%, B=50%

t=20 min, A=5%, B=95%

t=25 min, A=5%, B=95%

t=30 min, A=90%, B=10%

Table 2: SRM transitions used for detection and quantification (SRM #1) and confirmation (SRM #2)

Compound

SRM #1

CE (V)

SRM #2

CE (V)

Tube Lens

Pyrimethamine

249.10 177.07

40

Sulfamethoxazole

254.08 92.11

36

254.08 108.10

37

70

Diaveridine

261.15 123.11

34

Trimethoprim

291.16 123.10

33

291.16 230.17

34

91

Ciprofloxacin

332.16 231.07

49

332.16 288.15

27

82

Lomefloxacin

352.17 265.13

34

Levofloxacin

362.17 261.12

35

362.17 221.05

43

92

Clarithromycin*

748.55 590.36

19

748.55 115.99

35

96

Azithromycin*

375.33 82.96

25

749.54 158.04

38

74/112

Josamycin

828.53 108.87

46

828.53 173.96

47

126

Quantified using diaveridine as the internal standard,

Quantified using lomefloxacin as the internal standard, *Quantified using josamycin as the internal standard

Table 3: Analytical method parameters

Limit of Detection Standard SRM Sample SRM SRM ratio

Compound

r

2

matrix*

(ngL

-1

)

ratio±SD†

ratio±SD‡

difference^

Sulfamethoxazole

0.9995

22

1.53 ± 0.03

1.6 ± 0.2

-2.6

Trimethroprim

0.9998

7

4.2 ± 0.1

4.39 ± 0.07

-3.3

Ciprofloxacin

0.9996

21

5.5 ± 0.8

6.59 ± 0.05

-18.9

Levofloxacin

0.9996

4

3.65 ± 0.07

3.83 ± 0.06

-5.0

Clarithromycin

0.9997

0.3

1.67 ± 0.04

1.59 ± 0.09

4.3

Azithromycin

0.9900

12

1.2 ± 0.1

0.44 ± 0.1

6.4

*Determination coefficient of the calibration curve made using the WWTP effluent diluted by a factor of 10; **Calculated from the effluent data based on a S/N=3;

Standards spiked WWTP effluent diluted by a factor of 10, n=4;

WWTP effluent, n=3;

^

Percentage difference between the standard and sample SRM ratio.